A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumors.
- DOI
- 10.1038/s41698-026-01340-1
- Published
- 2026 Feb 28
- Container
- NPJ precision oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41698-026-01340-1,
title = {A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumors.},
author = {Falchook G and Braganca Xavier C and Van Veenhuyzen D and Malhotra J and Sadeghi S and Kalebasty AR and Wood L and Rahman F and Li E and Pak Y and Khalil M and Spira AI and Sommerhalder D and Garrido-Laguna I and Hong DS},
year = {2026},
journal = {NPJ precision oncology},
doi = {10.1038/s41698-026-01340-1},
url = {https://doi.org/10.1038/s41698-026-01340-1}
}RIS
TY - JOUR TI - A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumors. AU - Falchook G AU - Braganca Xavier C AU - Van Veenhuyzen D AU - Malhotra J AU - Sadeghi S AU - Kalebasty AR AU - Wood L AU - Rahman F AU - Li E AU - Pak Y AU - Khalil M AU - Spira AI AU - Sommerhalder D AU - Garrido-Laguna I AU - Hong DS PY - 2026 JO - NPJ precision oncology DO - 10.1038/s41698-026-01340-1 UR - https://doi.org/10.1038/s41698-026-01340-1 ER -
APA
G, F., C, B. X., D, V. V., J, M., S, S., AR, K., L, W., F, R., E, L., Y, P., M, K., AI, S., D, S., I, G., & DS, H. (2026). A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumors.. NPJ precision oncology. https://doi.org/10.1038/s41698-026-01340-1
Source records
- pubmed · retrieved 2026-09-26T13:58:26.933Z